Waddington R J, Embery G, Samuels R H
Department of Basic Dental Science, Dental School, University of Wales College of Medicine, Cardiff, U.K.
Arch Oral Biol. 1994 May;39(5):361-8. doi: 10.1016/0003-9969(94)90165-1.
Previous studies have identified glycosaminoglycans in gingival crevicular fluid (GCF) associated with a variety of clinical conditions, notably those involving bone resorptive activity. GCF was here collected from around teeth undergoing active orthodontic movement. Proteoglycan metabolites were purified from GCF by anion-exchange chromatography using fast performance liquid chromatography. Sulphated glycosaminoglycan was associated with the most highly anionic protein fractions IV, V and VI, and biochemical analysis was restricted to these fractions. Analysis included glycosaminoglycan content by cellulose acetate electrophoresis, molecular size by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), Western blotting and amino acid analyses. Fraction IV contained hyaluronan (18.7%) and chondroitin sulphate (10.9%), fraction V heparan sulphate (29.5%) and chondroitin sulphate (19.6%) and fraction VI chondroitin sulphate only (21.3%). SDS-PAGE revealed two Coomassie blue bands in fraction V of 72 and 60 kDa and two further bands in fraction VI of 71 and 56 kDa. These proteoglycans appeared resistant to digestion by chondroitinase ABC or heparinase III, although the glycosaminoglycan chains underwent degradation after protein-core removal. The molecular mass and amino acid composition of the chondroitin sulphate proteoglycan fractions showed a close similarity to those of human alveolar bone proteoglycan. The presence of heparan sulphate proteoglycan in GCF in association with orthodontic movement is in accord with previous reports. The findings support the view that proteoglycans in GCF are 'biomarkers', notably those associated with active resorption of alveolar bone.
以往的研究已在龈沟液(GCF)中鉴定出与多种临床状况相关的糖胺聚糖,尤其是那些涉及骨吸收活性的状况。此处收集了来自正在进行正畸牙齿移动周围的龈沟液。使用快速高效液相色谱通过阴离子交换色谱法从龈沟液中纯化蛋白聚糖代谢物。硫酸化糖胺聚糖与阴离子性最强的蛋白组分IV、V和VI相关,并且生化分析仅限于这些组分。分析包括通过醋酸纤维素电泳测定糖胺聚糖含量、通过十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳(SDS - PAGE)测定分子大小、蛋白质印迹法和氨基酸分析。组分IV含有透明质酸(18.7%)和硫酸软骨素(10.9%),组分V含有硫酸乙酰肝素(29.5%)和硫酸软骨素(19.6%),组分VI仅含有硫酸软骨素(21.3%)。SDS - PAGE显示组分V中有两条考马斯亮蓝带,分子量分别为72 kDa和60 kDa,组分VI中有另外两条带,分子量分别为71 kDa和56 kDa。这些蛋白聚糖似乎对软骨素酶ABC或肝素酶III的消化具有抗性,尽管在去除蛋白核心后糖胺聚糖链会发生降解。硫酸软骨素蛋白聚糖组分的分子量和氨基酸组成与人类牙槽骨蛋白聚糖的分子量和氨基酸组成非常相似。龈沟液中硫酸乙酰肝素蛋白聚糖与正畸移动相关的存在与先前的报道一致。这些发现支持了龈沟液中的蛋白聚糖是“生物标志物”这一观点,尤其是那些与牙槽骨的活跃吸收相关的蛋白聚糖。